133 related articles for article (PubMed ID: 35917200)
21. microRNA-150 targets major epigenetic repressors and inhibits cell proliferation.
Selvam M; Bandi V; Ponne S; Ashok C; Baluchamy S
Exp Cell Res; 2022 Jun; 415(1):113110. PubMed ID: 35351403
[TBL] [Abstract][Full Text] [Related]
22. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289
[TBL] [Abstract][Full Text] [Related]
23. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability.
Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P
Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321
[TBL] [Abstract][Full Text] [Related]
24. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
[No Abstract] [Full Text] [Related]
25. [Epigenetic aberrations in adult T-cell leukemia/lymphoma and development of a novel EZH1/2 inhibitor].
Yamagishi M
Rinsho Ketsueki; 2018; 59(4):432-438. PubMed ID: 29743404
[TBL] [Abstract][Full Text] [Related]
26. EZH1/2 as targets for cancer therapy.
An R; Li YQ; Lin YL; Xu F; Li MM; Liu Z
Cancer Gene Ther; 2023 Feb; 30(2):221-235. PubMed ID: 36369341
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
28. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
29. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
30. Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Nakagawa M; Fujita S; Katsumoto T; Yamagata K; Ogawara Y; Hattori A; Kagiyama Y; Honma D; Araki K; Inoue T; Kato A; Inaki K; Wada C; Ono Y; Yamamoto M; Miura O; Nakashima Y; Kitabayashi I
Cancer Sci; 2019 Jan; 110(1):194-208. PubMed ID: 30343511
[TBL] [Abstract][Full Text] [Related]
31. Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation.
Dror N; Mandel M; Lavie G
PLoS One; 2013; 8(9):e73625. PubMed ID: 24066060
[TBL] [Abstract][Full Text] [Related]
32. A cytosolic Ezh1 isoform modulates a PRC2-Ezh1 epigenetic adaptive response in postmitotic cells.
Bodega B; Marasca F; Ranzani V; Cherubini A; Della Valle F; Neguembor MV; Wassef M; Zippo A; Lanzuolo C; Pagani M; Orlando V
Nat Struct Mol Biol; 2017 May; 24(5):444-452. PubMed ID: 28346433
[TBL] [Abstract][Full Text] [Related]
33. EZH2 is essential for glioblastoma cancer stem cell maintenance.
Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues.
Ahani N; Shirkoohi R; Rokouei M; Alipour Eskandani M; Nikravesh A
Med Oncol; 2014 Nov; 31(11):252. PubMed ID: 25294424
[TBL] [Abstract][Full Text] [Related]
35. Maternal Ezh1/2 deficiency in oocyte delays H3K27me2/3 restoration and impairs epiblast development responsible for embryonic sub-lethality in mouse.
Zhao Y; Bai D; Wu Y; Zhang D; Liu M; Tian Y; Lu J; Wang H; Gao S; Lu Z
Development; 2022 Aug; 149(15):. PubMed ID: 35796552
[TBL] [Abstract][Full Text] [Related]
36. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.
Zhu WS; Tang CM; Xiao Z; Zhu JN; Lin QX; Fu YH; Hu ZQ; Zhang Z; Yang M; Zheng XL; Wu SL; Shan ZX
Oncotarget; 2016 Nov; 7(48):78331-78342. PubMed ID: 27823969
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.
Kim E; Kim M; Woo DH; Shin Y; Shin J; Chang N; Oh YT; Kim H; Rheey J; Nakano I; Lee C; Joo KM; Rich JN; Nam DH; Lee J
Cancer Cell; 2013 Jun; 23(6):839-52. PubMed ID: 23684459
[TBL] [Abstract][Full Text] [Related]
38. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J; Cheng P; Pavlyukov MS; Yu H; Zhang Z; Kim SH; Minata M; Mohyeldin A; Xie W; Chen D; Goidts V; Frett B; Hu W; Li H; Shin YJ; Lee Y; Nam DH; Kornblum HI; Wang M; Nakano I
J Clin Invest; 2017 Aug; 127(8):3075-3089. PubMed ID: 28737508
[TBL] [Abstract][Full Text] [Related]
39. Ezh1 arises from Ezh2 gene duplication but its function is not required for zebrafish development.
Völkel P; Bary A; Raby L; Chapart A; Dupret B; Le Bourhis X; Angrand PO
Sci Rep; 2019 Mar; 9(1):4319. PubMed ID: 30867490
[TBL] [Abstract][Full Text] [Related]
40. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin.
Son J; Shen SS; Margueron R; Reinberg D
Genes Dev; 2013 Dec; 27(24):2663-77. PubMed ID: 24352422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
